九典制药两种药品获准开展临床试验

Core Viewpoint - The company has received approval from the National Medical Products Administration for clinical trials of two drugs, indicating progress in its research and development efforts [1] Group 1: Clinical Trials - The approved clinical trials include JIZM01 for closed soft tissue contusions and joint sprains [1] - The second trial is for JIZM02, which targets shoulder periarthritis [1]